Polish pharmaceutical Adamed heads for Saudi Arabia

Adamed became interested in Saudi Arabia only after the government, together with the National Economics Chamber (KIG), had sent representatives there in a mission to help establish economic links between the countries. "Thanks to [the mission], we met a business partner that is one of the leading local pharmaceutical distributors. We have been researching the market for a year and have developed the most profitable cooperation model. We signed an agreement in September," said Sławomir Mirek, Adamed's managing director. The Saudi Arabian drug registration procedures should close by the end of 2005 and Adamed's products should be available on the market by 2006. The company is the leader in this country's market for new generation drugs used in cardiology, psychiatry, lung treatment and gynecology. Adamed owns two factories in Pieńków and Ksawerów. Established in 1986, Adamed enjoyed an income of zł.158 million in 2003, with a net profit of zł.9.9 million. (Parkiet, p. 6) D.W.